Independent Directors review Bhardwaj family open offer for 26% stake

The Committee of Independent Directors of Onyx Biotec met on October 7, 2026 to review an Open Offer from Mr Kunal, Mr Gautam, Mr Kanhaiya and Mr Kapil Bhardwaj. The acquirers seek up to 47,14,372 equity shares of Rs 10 face value, equalling 26% of paid-up capital, under SEBI SAST Regulations 3(1) and 4. The committee recommendation will be published in the same newspapers as the July 31, 2026 Detailed Public Statement and shared with SEBI, NSE and VC Corporate Advisors.